P-Hydroxybenzaldehyde

Identification

Generic Name
P-Hydroxybenzaldehyde
DrugBank Accession Number
DB03560
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 122.1213
Monoisotopic: 122.036779436
Chemical Formula
C7H6O2
Synonyms
Not Available
External IDs
  • FEMA NO. 3984

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Calcium carbimideThe risk or severity of adverse effects can be increased when Calcium carbimide is combined with P-Hydroxybenzaldehyde.
DisulfiramThe risk or severity of adverse effects can be increased when Disulfiram is combined with P-Hydroxybenzaldehyde.
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as hydroxybenzaldehydes. These are organic aromatic compounds containing a benzene ring carrying an aldehyde group and a hydroxyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Hydroxybenzaldehydes
Alternative Parents
Benzoyl derivatives / 1-hydroxy-2-unsubstituted benzenoids / Organic oxides / Hydrocarbon derivatives
Substituents
1-hydroxy-2-unsubstituted benzenoid / Aromatic homomonocyclic compound / Benzenoid / Benzoyl / Hydrocarbon derivative / Hydroxybenzaldehyde / Monocyclic benzene moiety / Organic oxide / Phenol
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
hydroxybenzaldehyde (CHEBI:17597) / a small molecule (4-HYDROXYBENZALDEHYDE)
Affected organisms
Not Available

Chemical Identifiers

UNII
O1738X3Y38
CAS number
123-08-0
InChI Key
RGHHSNMVTDWUBI-UHFFFAOYSA-N
InChI
InChI=1S/C7H6O2/c8-5-6-1-3-7(9)4-2-6/h1-5,9H
IUPAC Name
4-hydroxybenzaldehyde
SMILES
OC1=CC=C(C=O)C=C1

References

Synthesis Reference

Masao Kawamura, Tadaaki Nishi, Kunioki Kato, Hiroshi Mizokami, Tadashi Kanazawa, "Process for producing p-hydroxybenzaldehyde." U.S. Patent US4195041, issued January, 1968.

US4195041
General References
Not Available
Human Metabolome Database
HMDB0011718
KEGG Compound
C00633
PubChem Compound
126
PubChem Substance
46509028
ChemSpider
123
BindingDB
50177411
ChEBI
17597
ChEMBL
CHEMBL14193
ZINC
ZINC000000156709
PDBe Ligand
HBA
Wikipedia
4-Hydroxybenzaldehyde
PDB Entries
1eb9 / 1k03 / 1oyb / 1z42 / 2gq9 / 2vq5 / 3atz / 3hgj / 3zoc / 3zoe
show 12 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)117 °CPhysProp
boiling point (°C)310 °CPhysProp
water solubility8450 mg/L (at 25 °C)JIN,LJ ET AL. (1998)
logP1.35HANSCH,C ET AL. (1995)
logS-0.96ADME Research, USCD
pKa7.61 (at 25 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
Water Solubility9.51 mg/mLALOGPS
logP1.27ALOGPS
logP1.38Chemaxon
logS-1.1ALOGPS
pKa (Strongest Acidic)7.32Chemaxon
pKa (Strongest Basic)-7.1Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area37.3 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity34.62 m3·mol-1Chemaxon
Polarizability11.98 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9974
Blood Brain Barrier+0.8471
Caco-2 permeable+0.9481
P-glycoprotein substrateNon-substrate0.8071
P-glycoprotein inhibitor INon-inhibitor0.9733
P-glycoprotein inhibitor IINon-inhibitor0.9834
Renal organic cation transporterNon-inhibitor0.8807
CYP450 2C9 substrateNon-substrate0.7895
CYP450 2D6 substrateNon-substrate0.9182
CYP450 3A4 substrateNon-substrate0.744
CYP450 1A2 substrateNon-inhibitor0.7521
CYP450 2C9 inhibitorNon-inhibitor0.9852
CYP450 2D6 inhibitorNon-inhibitor0.9701
CYP450 2C19 inhibitorNon-inhibitor0.9056
CYP450 3A4 inhibitorNon-inhibitor0.9155
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9288
Ames testNon AMES toxic0.9594
CarcinogenicityNon-carcinogens0.7816
BiodegradationReady biodegradable0.8962
Rat acute toxicity1.8909 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9103
hERG inhibition (predictor II)Non-inhibitor0.9768
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00di-6900000000-ea309e8826550692ddeb
GC-MS Spectrum - EI-BGC-MSsplash10-00di-8900000000-4eff34096f6bd4f30d10
GC-MS Spectrum - EI-BGC-MSsplash10-00di-9800000000-c8646d08ef8e23a3d49b
GC-MS Spectrum - EI-BGC-MSsplash10-00di-8900000000-60621d4d9871b2d7587d
GC-MS Spectrum - EI-BGC-MSsplash10-05i0-1970000000-7ef151eab685361413a6
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00b9-1940000000-fa6b812457f26dce7720
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00b9-2940000000-0bfc68ade3f25f6ba1f2
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00b9-2940000000-b50ed8954cb10b92a30b
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00b9-2930000000-671031e52722de3402ec
Mass Spectrum (Electron Ionization)MSsplash10-00di-9500000000-2c1739a8a2bc288e4a5c
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-00di-0900000000-99136b39c7ec11a7bbca
MS/MS Spectrum - , negativeLC-MS/MSsplash10-00di-0900000000-ab4c213ba9a645517aa3
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00dj-9800000000-a83c678d5e0087cd414b
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00dl-7900000000-426ba35bd7299560373a
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-006x-9400000000-fca8fbff3ab835be1150
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-9000000000-2453b1e06f1a02827724
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0v00-9000000000-d4a21e228f182eaa66d7
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kf-9000000000-79af46858f21653cab80
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-122.6001474
predicted
DarkChem Lite v0.1.0
[M-H]-122.4035474
predicted
DarkChem Lite v0.1.0
[M-H]-122.5086474
predicted
DarkChem Lite v0.1.0
[M-H]-120.126884
predicted
DeepCCS 1.0 (2019)
[M+H]+122.5314474
predicted
DarkChem Lite v0.1.0
[M+H]+127.1972474
predicted
DarkChem Lite v0.1.0
[M+H]+123.2122474
predicted
DarkChem Lite v0.1.0
[M+H]+123.837585
predicted
DeepCCS 1.0 (2019)
[M+Na]+122.7659474
predicted
DarkChem Lite v0.1.0
[M+Na]+122.8143474
predicted
DarkChem Lite v0.1.0
[M+Na]+132.63777
predicted
DeepCCS 1.0 (2019)

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52